HOME
ABOUT US
TECHNOLOGY
PRODUCTS
MEDIA
CAREERS
CONTACT
More
Gene therapy to cure leukemia at one-tenth global costs
June 12, 2022
The Mexican government has partnered with ImmunoAct, an IIT Bombay-incubated company which is developing cutting-edge CAR -T cell
March 08, 2023
Homegrown CAR-T cells 'cure' 8-year-old's leukemia
October 23, 2022
ImmunoACT Advances Plans For Cut-Price CAR-T In India
June 30, 2022
Indigenous CAR T Therapy to be soon available in India
June 14, 2022
IIT Bombay incubated company provides ray of hope for blood cancers in India
ImmunoACT sets up a state-of-art facility for its Phase 2/3 CAR T cell therapy trials
Afforbable CAR T Therapy - Interview of ImmunoACT founder
June 13, 2022
Laurus Labs to buy 26% in CAR T-cell therapy company
November 20, 2021